President Donald Trump said on Wednesday that there will be a tariff "wall" for pharmaceutical companies operating in the ...

A Cambridge-based pharmaceutical company reported to the state that it is laying off close to a hundred employees.

The pharma industry’s reputation dropped slightly again among patient groups, largely due to drug pricing issues.

Whilst 2025 outlooks include cost impacts from existing tariffs, companies have not adjusted their guidance for future pharma ...

The expiration of the TRIPS waiver is just one aspect of a broader set of challenges that the industry will need to address.

But international agreements are notoriously difficult to enforce, and pharma companies and patient advocates who were ...

Uncertainties around US tariffs and the end of the limited competition period for generic Revlimid in the US will loom in ...

President Trump announced a tariff “wall” for pharmaceutical companies in the US, potentially raising drug prices by nearly ...

The U.S. Food and Drug Administration is asking some of its recently fired staff responsible for critically important funding ...

Drugmaker executives have projected confidence they can mitigate the impact of any levies Trump imposes on the industry. Yet ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2025 investor letter. A ...

Tariffs will likely cost Deerfield-based Baxter International $60 million to $70 million this year, the company’s chief ...